Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence
Zhong Wu(Nanfang Hospital), Adam J. Bass(Dana-Farber Cancer Institute), Kwok‐Kin Wong(NYU Langone Health), Arpit Panda(Harvard University), Anil K. Rustgi(Columbia University Irving Medical Center), Klothilda Lim(Dana-Farber Cancer Institute), Longlong Si(Chinese Academy of Sciences), Myles Brown(Harvard University), Jie Bin Liu(Dana-Farber Cancer Institute), Ji Yeon Baek(Harvard University), Louisa B. Goss(Harvard University), Jonathan P. Katz(Hospital of the University of Pennsylvania), Xintao Qiu(Dana-Farber Cancer Institute), Hiroshi Nakagawa(University of Pennsylvania), Zhouwei Zhang(Van Andel Institute), Deepa T. Patil(Brigham and Women's Hospital), Matthew Meyerson(Broad Institute), Yingtian Xie(Dana-Farber Cancer Institute), David A. Barbie(Dana-Farber Cancer Institute), Nikolas Kesten(Dana-Farber Cancer Institute), Jin Zhou(The University of Texas Southwestern Medical Center), Ankur K. Nagaraja(Novartis (Switzerland)), Henry W. Long(Dana-Farber Cancer Institute), Jeffrey J. Ishizuka(Broad Institute), James M. McFarland(Broad Institute), Josephine Hai(Harvard University), Jun Qi(Georgia Institute of Technology), Matthew D. Stachler(University of California, San Francisco), Yanxi Zhang(Guangdong University of Technology), Fahire G. Akarca(University of California, San Francisco), Zandra V. Ho(Broad Institute), Israel Cañadas(Fox Chase Cancer Center), Xiaoyang Zhang(University of Utah), Yang Liu(Harbin Medical University), Paloma Cejas(Dana-Farber Cancer Institute), Yanli Liu(National Medical Products Administration), Chunyang Bao(University of California San Diego)
Cited by 111
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k